The potential of brief interventions and medication in reducing alcohol consumption in alcohol dependent individuals;Können Alkoholabhängige ihre Trinkmengen durch eine Kombination von Medikamenten und Kurzinterventionen dauerhaft reduzieren?

Sucht

Volumn 61, Issue 1, 2015, Pages 29-36

  Mann, Karl ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Abstinence; Alcohol dependence; Nalmefene; Reduced drinking; Treatment goals

Indexed keywords

NALMEFENE; PLACEBO;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; EUROPEAN MEDICINES AGENCY; GENERAL PRACTITIONER; HARM REDUCTION; HUMAN;

EID: 84923650209     PISSN: 09395911     EISSN: None     Source Type: Journal    
DOI: 10.1024/0939-5911.a000346     Document Type: Article

References (55)

1. Adamson, S. J., Heather, N., Mortan, V. & Raistrick, D. (2010). Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes. Alcohol and alcoholism, 45 (2), 136-142.
2. Ambrogne, J.A. (2002). Reduced-risk drinking as a treatment goal: what clinicians need to know. Journal of substance abuse treatment, 22, 45-53.
3. Anton, R.F., OMalley, S.S., Ciraulo, D.A., Cisler, R.A., Couper, D., Donovan, D.M. et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA, 295, 2003-2017.
4. Apodaca, T.R. & Miller, W.R. (2003). A meta-analysis of the effectiveness of bibliotherapy for alcohol problems. Journal of clinical psychology, 59, 289-304.
5. Bart, G., Schluger, J. H., Borg, L., Ho, A., Bidlak, J.M. & Kreek, M.M. (2005). Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity? Neuropsychopharmacology, 30, 2254-2262.
6. EMA (European Medicines Agency). (2011). Annual report 2010 (adopted by the management board June 28, 2011). EMA/306870/2011.
7. Zugriff am 05. 12. 2014. Verfgbar unter http://www.ema.europa.eu/
8. EMA (European Medicines Agency). (2013). Assessment report 2012. http://www.ema.europa.eu/
9. Gastfriend, D. R., Garbutt, J.C., Pettinati, H.M. & Forman, R.F. (2007). Reduction in heavy drinking as a treatment outcome in alcohol dependence. Journal of Substance Abuse Treatment, 33, 71-80.
10. Gemeinsamer Bundesausschuss (GBA). (2014). Mittel zur Behandlung der Alkoholabhngigkeit unter bestimmten Voraussetzungen knftig zulasten der GKV verordnungsfhig. Pressemitteilung, 20. 02. 2014.
11. Zugriff am 05. 12. 2014. Verf gbar unter https://www.g-ba.de/institution/presse/pressemi tteilungen/519/
12. Gual, A., He, Y., Torup, L., van den Brink, W., et al. (2013). A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. European neuropsychopharmacology, 23, 1432-1442.
13. Gnthner, A., Weissinger, V., Fleischmann, H., Veltrup, C., Jpel, B., Lngle, G. et al. (2015). Versorgungsorganisation. In Deutsche Gesellschaft fr Suchtforschung und Suchttherapie & Deutsche Gesellschaft fr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (Hrsg.) S3-Leitlinie. Verfgbar unter: http://www.awmf.org/leitlinien.html), im Druck.
14. Heather, N., Adason, S. J., Raistrick, D. & Sleg, G.P. (2010). Initial preference for drinking goal in the treatment of alcohol problems: I. Baseline differences between abstinence and nonabstinence groups. Alcohol and alcoholism, 45, 128-135.
15. Hodgins, D.C., Leigh, G., Milne, R. & Gerrish, R. (1997). Drinking goal selection in behavioral self-management treatment of chronic alcoholics. Addictive Behaviors, 22, 247-255.
16. Jackson, R., Johnson, M., Campbell, F., Messina, J., Guillaume, L., Meier, P., et al. (2010). Screening and brief interventions for prevention and early identification of alcohol use disorders in adults and young people. Sheffield: University of Sheffield, School of Health and Related Research (ScHARR), Public Health Collaborating Centre.
17. Johnson, B.A., Rosenthal, N., Capece, J.A., Wiegand, F., Mao, L., Beyers, K., et al. (2007). Topiramate for treating alcohol dependence: A randomized controlled trial. JAMA, 298, 1641-1651.
18. Johnson, B.A., Ait-Daoud, N., Bowden, C. L., DiClemente, C.C., Roache, J.D., Lawson, K. et al. (2003). Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet, 361, 1677-1685.
19. Kaner, E.F., Beyer, F., Dickinson, H.O., Pienaar, E., Campbell, F., Schlesinger, C., et al. (2007). Effectiveness of brief alcohol interventions in primary care populations. CochraneDatabase of Systematic Reviews, DOI: 10.1002/14651858.CD004148.pub3.
20. Karhuvaara, S., Simojoki, K., Virta, A., Rosberg, M., et al (2007). Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. Alcoholism: clinical and experimental research, 31, 1179-1187.
21. Khadjesari, Z., Murray, E., Hewitt, C., Hartley, S., & Godfrey, C. (2011). Can stand-alone computer-based interventions reduce alcohol consumption? A systematic review. Addiction, 106, 267-282.
22. Kçrkel, J. (2010). Kontrolliertes Trinken: Wissenschaftliche Fakten versus Mystizismus. In K. Wassenberg & S. Schaller (Hrsg.). Der Geist der Deutschen Mßigkeitsbewegung: Debatten um Alkohol und Trinken in Vergangenheit und Gegenwart (S. 166-179). Halle: Mitteldeutscher Verlag.
23. Kohn, R., Saxena, S., Levav, I. & Sarceno, B. (2004). The treatment gap in mental health care. Bulletin of the World Health Organization, 82, 858-866.
24. Lundahl, B. & Burke, B.L. (2009). The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. Journal of Clinical Psychology, 65, 1232-1245.
25. Mann, K. (2004) Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18, 485-504.
26. Mann, K., Lem nager, T., Hoffmann, S., Reinhard, I., Hermann, D., Batra, A. et al. (2012). Results of a double-blind, placebocontrolled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addiction biology, 18, 937-946.
27. Mann, K. & Kçrkel, J. (2013). Trinkmengenreduktion: ein ergnzendes Therapieziel bei Alkoholabhngigen? Psychopharmakotherapie, (5), 193-198.
28. Mann, K., Bladstrom, A., Torup, L., Gual, A. & v.d. Brink, W. (2013). Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biological Psychiatry, 73, 706-713.
29. Mason, B., J., Ritvo, E., C., Morgan, R., O., Salvato, F., R., et al. (1994). A double-blind, placebo-controlled Pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcoholism: Clinical and Experimental Research, 18, 1162-1167.
30. Mason, B. J., Salvato, F.R., Williams, L.D., Ritvo, E.C., et al. (1999). Adouble-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Archives of general psychiatry, 56(8), 719-724.
31. McQueen, J., Howe, T.E., Allan, L. & Mains, D. (2009). Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD005191.pub3.
32. Moreira, M.T., Smith, L.A. & Foxcroft, D.. (2009). Social norms interventions to reduce alcohol misuse nuniversity or college students. Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD006748.pub2.
33. NICE National Institute for Health and Clinical Excellence. (2011). Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (CG 115). London: National Institute for Health and Clinical Excellence.
34. Orford, J. & Keddie, A. (1986). Abstinence or controlled drinking in clinical practice: a test of the dependence and persuasion hypotheses. British Journal of Addiction, 81, 495-504.
35. Pabst, A., Kraus, L., Gomes de Matos, E., & Piontek, D. (2013). Substanzkonsum und substanzbezogene Stçrungen in Deutschland im Jahr 2012. Sucht, 59, 321-331.
36. Rehm, J., Rehm, M., Shield, K.V., Gmel, G., Frick, U. & Mann, K. (2014) Reduzierung alkoholbedingter Mortalitt durch Behandlung der Alkoholabhngigkeit. SUCHT, 60, 93-105.
37. Rçsner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S. & Soyka, M. (2010a). Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD004332.pub2.
38. Rçsner, S., Hackl-Herrwerth, A., Leucht, S., Vecchi, S., Srisurapanont, M. & Soyka, M. (2010b). Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.CD001867.pub3.
39. Rooke, S., Thorsteinsson, E., Karpin, A., Copeland, J. & Allsop, D. (2010). Computer-delivered interventions for alcohol and tobacco use: a meta-analysis. Addiction, 105, 1381-1390.
40. Rosenberg, H., Melville, J., Levell, D. & Hodge, J. E. (1992). A 10-year follow-up survey of acceptability of controlled drinking in Britain. Journal of Studies on Alcohol, 53, 441-446.
41. Saladin, M., Santa Ana, E. (2004). Controlled drinking: More than just a controversy. Current Opinion in Psychiatry, 17, 175-87.
42. Substance Abuse and Mental Health Services Administration (SAMSHA). (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHSPublicationNo. (SMA) 14-4863. Rockville, MD: Substance Abuse and Mental Health Services Administration.
43. Zugriff am 05. 06.2014 unter http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf
44. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, Suppl 20, 22-33.
45. Smedslund, G., Berg, R.C., Hammerstrom, K.T., Steiro, A., Leiknes, K.A., Dahl, H.M. et al. (2011). Motivational interviewing for substance abuse. Cochrane Database of Systematic Reviews. Doi: 10.1002/14651858.CD008063.pub2.
46. Sobell, M.B. & Sobell, L.C. (1973). Alcoholics treated by individualized behavior therapy: one year treatment outcome. Behaviour research and therapy, 11, 599-618.
47. Sobell, M.B. & Sobell, L.C. (1976). Second year treatment outcome of alcoholics treated by individualized behaviour therapy: results. Behaviour research and therapy, 14, 195-215.
48. Sobell, L.C. & Sobell, M.B. (1992). Timeline follow-back: A technique for assessing self-reported ethanol consumption. In R.Z. Litten, R.Z. & J.P. Allen (Eds.). Measuring Alcohol Consumption: Psychosocial and Biological Methods (S. 41-72). Totowa, New Jersey: Humana Press.
49. Sobell, M.B. & Sobell, L.C. (1995). Controlled drinking after 25 years: how important was the great debate? Addiction, 90, 1149-53; discussion 57-77.
50. Starosta, A., N., Leeman, R., F. & Volpicelli, J. (2006). The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders. Journal of psychiatric practice, 12, 80-89.
51. UKATT (2005). Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ (Clinical research ed), 331(7516), 544.
52. van den Brink, W., Sørensen, P., Torup, L., Mann, K., Gual, A.; for the SENSE Study Group (2014). Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study. Journal of Psychopharmacology, 26, 733-744.
53. Walters, G. (2000). Behavioral self-control training for problem drinkers: A meta-analysis ofurandomized control studies. Behavior Therapy, 31, 135-149.
54. Wienberg, G. (2002). Systems of care for persons with alcohol problems in Germany-an analysis from a public health perspective. In K. Mann (Hrsg.). Neue Therapieanstze bei Alkoholproblemen (S. 17-46). Lengerich: Pabst.
55. Witkiewitz, K. (2008). Lapses following alcohol treatment: modeling the falls from the wagon. Journal of Studies on Alcohol and Drugs, 69, 594-604.